Aeglea BioTherapeutics Inc (AGLE) - Financial and Strategic SWOT Analysis Review

  • ID: 4285172
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Aeglea BioTherapeutics
1 of 4

Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company’s product pipeline comprises AEB1102, AEB3103, AEB2109, and AEB4104. It develops engineered human enzymes to target and degrade amino acids in the blood. Aeglea BioTherapeutics is developing products for the treatment of Arginase I Deficiency; homocystinuria and others. The company works in partnership with research institutions, allied healthcare providers and pharmaceutical companies to discover, develop and market new product candidates. Aeglea BioTherapeutics is headquartered in Austin, Texas, the US.

Aeglea BioTherapeutics Inc Key Recent Developments

Nov 07, 2017: Aeglea BioTherapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results
Aug 09, 2017: Aeglea BioTherapeutics Provides Corporate Update and Reports Second Quarter 2017 Financial Results
Jul 20, 2017: Aeglea BioTherapeutics Announces Leadership Change
Jul 10, 2017: Aeglea BioTherapeutics Appoints James Wooldridge, M.D. as Chief Medical Officer
May 09, 2017: Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2017 Financial Results

This comprehensive SWOT profile of Aeglea BioTherapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aeglea BioTherapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Aeglea BioTherapeutics Inc - Key Information
  • Aeglea BioTherapeutics Inc - Overview
  • Aeglea BioTherapeutics Inc - Key Employees
  • Aeglea BioTherapeutics Inc - Key Employee Biographies
  • Aeglea BioTherapeutics Inc - Key Operational Heads
  • Aeglea BioTherapeutics Inc - Major Products and Services
  • Aeglea BioTherapeutics Inc - History
  • Aeglea BioTherapeutics Inc - Company Statement
  • Aeglea BioTherapeutics Inc - Locations And Subsidiaries
  • Aeglea BioTherapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Aeglea BioTherapeutics Inc - Business Description
  • Aeglea BioTherapeutics Inc - Corporate Strategy
  • Aeglea BioTherapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Aeglea BioTherapeutics Inc - Strengths
  • Aeglea BioTherapeutics Inc - Weaknesses
  • Aeglea BioTherapeutics Inc - Opportunities
  • Aeglea BioTherapeutics Inc - Threats
  • Aeglea BioTherapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Aeglea BioTherapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Aeglea BioTherapeutics Inc, Key Information
  • Aeglea BioTherapeutics Inc, Key Ratios
  • Aeglea BioTherapeutics Inc, Share Data
  • Aeglea BioTherapeutics Inc, Major Products and Services
  • Aeglea BioTherapeutics Inc, History
  • Aeglea BioTherapeutics Inc, Key Employees
  • Aeglea BioTherapeutics Inc, Key Employee Biographies
  • Aeglea BioTherapeutics Inc, Key Operational Heads
  • Aeglea BioTherapeutics Inc, Other Locations
  • Aeglea BioTherapeutics Inc, Subsidiaries
  • Aeglea BioTherapeutics Inc, Key Manufacturing facilities
  • Aeglea BioTherapeutics Inc, Key Competitors
  • Aeglea BioTherapeutics Inc, SWOT Analysis
  • Aeglea BioTherapeutics Inc, Ratios based on current share price
  • Aeglea BioTherapeutics Inc, Annual Ratios
  • Aeglea BioTherapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Aeglea BioTherapeutics Inc, Performance Chart
  • Aeglea BioTherapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown